Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth
- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology and Company Leadership...
Month: November 2024
BionicM Named as CES Innovation Awards® 2025 Best of Innovation
TOKYO, Nov. 15, 2024 /PRNewswire/ -- BionicM announces it has been named a CES Innovation Awards® 2025 BEST OF INNOVATION...
12 Lines of Code, Infinite Opportunities: How AidQuest is Shaping the Future of Home Care
BURLINGAME, Calif., Nov. 15, 2024 /PRNewswire/ -- In 2022, AidQuest transformed the home care industry with a seemingly simple solution: a...
Mindbloom and Happier Break New Ground with the Ultimate Fusion of Ketamine Therapy and Mindfulness
AUSTIN, Texas, Nov. 15, 2024 /PRNewswire/ -- Today, Mindbloom, the largest provider of psychedelic therapy, and Happier, the leading meditation and...
THIRA Health Welcomes Patricia Charles-Heathers, Ph.D., MPA, as New Executive Director
Seasoned Behavioral Health Leader Joins THIRA Health, Strengthening Commitment to Comprehensive Mental Health Care for Women and AdolescentsBELLEVUE, WA /...
DuneGlass Capital Announces the Launch of Aviva Aesthetics: The Industry’s Only Entrepreneur-Owned and Led Medical Aesthetics Platform
Aviva Aesthetics provides med spa owners with an alternative to private equity CHICAGO, IL and FULTON, MD / ACCESSWIRE /...
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders’ Equity Up 8.8% to $35M
Stable revenue and gross profit despite cost-cutting initiatives, indicating the strength of underlying segments and brands.Solid liquidity position, with cash...
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025Company...
CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated...
Justera Health Announces Management Change
TORONTO, ON / ACCESSWIRE / November 15, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce...
Encision Reports Second Quarter Fiscal Year 2025 Results
BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active...
Theralase(R) Closes Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / November 15, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial – Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID
SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed...
Samsung Bioepis Receives Positive CHMP Opinion for Denosumab Biosimilars, OBODENCE™ and XBRYK™
OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectivelyINCHEON, South...
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment...
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCEParsortix-based HER2 kit being developed...
Can Independent Physicians Survive in 2025?
Learn How at an Exclusive Webinar on Nov. 20th Hosted by Medical Economics and Specialdocs CHICAGO, Nov. 14, 2024 /PRNewswire/...
The Light Must Unite Declares November 11th as International Prayer Day for Global Peace
A Transformative Virtual Event Celebrates Unity, Hope, and Global Peace, Featuring Renowned Guests and Visionary LeadersNew York, New York--(Newsfile Corp....
Acreage Reports Third Quarter 2024 Financial Results
Launched non-medical sales in Ohio with initial sales accounting for 38% of total state level revenue in Q3 2024Capital infusion...
Defence Therapeutics Announces Securities for Debenture Financing
Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...